Director Deep Nishar resigns from Relay Therapeutics board

Relay Therapeutics, Inc.

Dipchand (Deep) Nishar resigned as Class III director effective December 8, 2021.
Resignation was not due to any dispute or disagreement with the company, management, or board.
No replacement director has been announced in this filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dipchand (Deep) Nishar

Class III director

RLAY · Relay Therapeutics, Inc.

Effective: 2021-12-08
Filed: December 9, 2021, 6:59 PM ET

On and effective as of December 8, 2021, Dipchand (Deep) Nishar tendered his resignation as a Class III director of the board of directors (the “Board”) of Relay Therapeutics, Inc. (the “Company”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dipchand (Deep) Nishar resigned as Class III director at Relay Therapeutics, Inc..

Action: resigned
Role: Class III director

Exact text from the filing

On and effective as of December 8, 2021, Dipchand (Deep) Nishar tendered his resignation as a Class III director of the board of directors (the “Board”) of Relay Therapeutics, Inc. (the “Company”).

View on SEC.gov

Relay Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001564590-21-059895

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.